Abstract
Elimination of protein expression using RNA interference (RNAi) significantly improves the understanding of gene function and represents a promising technique for the treatment of diseases such as cancer and neurological disorders. Accumulating evidence suggests the so-called interferon-independent non-specific gene silencing of short interfering RNA (siRNA); however, its biological and functional cellular consequences are largely unidentified. We therefore analyzed the effects of different nonsense siRNAs on characteristic bio-parameters such as cell viability, proliferation, cell cycle distribution, apoptosis, and migration of tumor cells. All analyzed cellular aspects have been observed to be significantly affected by the presence of siRNA in an interferon-independent manner: viability, mitosis, and motility were significantly diminished and programmed cell death was significantly elevated. Moreover, all cell cycle stages (G0/G1-, G2/M-, and S-phase) were moderately shifted. Together, these results support the hypothesis that siRNA, due to sequence-specific cellular consequences, modulate bio-functionality independent of the target sequence. This phenomenon affects the design of siRNA experiments for futurein vitro but also forin vivo tests as well as for potential therapeutic and preventive strategies. Moreover, monitoring interferon response after transfection of siRNAs is necessary but not sufficient to exclude potential off-target effects in non-diseased cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sen GL, Blau HM: A brief history of RNAi: the silence of the genes. Faseb J 20:1293–1299, 2006
Watanabe T, Sudoh M, Miyagishi M, et al: Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther 13:883–892, 2006
Xia X, Zhou H, Huang Y, et al: Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo. Neurobiol Dis 23:578–586, 2006
Ko K, Furukawa K, Takahashi T, et al: Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers. Oncogene 25:6924–6935, 2006
Romano PR, McCallus DE, Pachuk CJ: RNA interference-mediated prevention and therapy for hepatocellular carcinoma. Oncogene 25:3857–3865, 2006
Elbashir SM, Martinez J, Patkaniowska A, et al: Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate RNA interference is mediated by 21- and 22-nucleotide RNAs. Embo J 20:6877–6888, 2001
Kumar A, Haque J, Lacoste J, et al: Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A 91:6288–6292, 1994
Reynolds A, Anderson EM, Vermeulen A, et al: Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12:988–993, 2006
Persengiev SP, Zhu X, Green MR: Nonspecific, concentrationdependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12–18, 2004
Semizarov D, Frost L, Sarthy A, et al: Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci U S A 100:6347–6352, 2003
Jackson AL, Bartz SR, Schelter J, et al: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635–637, 2003
Kern MA, Schubert D, Sahi D, et al: Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology 36:885–894, 2002
Ehemann V, Hashemi B, Lange A, et al: Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas. Cancer Lett 138:101–106, 1999
Ehemann V, Sykora J, Vera-Delgado J, et al: Flow cytometric detection of spontaneous apoptosis in human breast cancer using the TUNEL-technique. Cancer Lett 194:125–131, 2003
Nicoletti I, Migliorati G, Pagliacci MC, et al: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271–279, 1991
Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, et al: Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 101:1892–1897, 2004
Doench JG, Petersen CP, Sharp PA: siRNAs can function as miRNAs. Genes Dev 17:438–442, 2003
Fedorov Y, Anderson EM, Birmingham A, et al: Off-target effects by siRNA can induce toxic phenotype. RNA 12:1188–1196, 2006
Ullu E, Tschudi C, Chakraborty T: RNA interference in protozoan parasites. Cell Microbiol 6:509–519, 2004
Jackson AL, Burchard J, Schelter J, et al: Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA 12:1179–1187, 2006
Jackson AL, Burchard J, Leake D, et al: Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA 12:1197–1205, 2006
Schwarz DS, Hutvagner G, Haley B, et al: Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell 10:537–548, 2002
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was financially supported by grants from the Deutsche Forschungsgemeinschaft (DFG; Schi 273/4-3), Dr. Mildred Scheel Stiftung für Krebsforschung (106178 to P. Schirmacher), the Ministry of Science, Research and the Arts of Baden-Württemberg (Az: 23-7532.22-23-12/1 to K. Breuhahn), and the Monika Kutzner Stiftung (to K. Breuhahn).
Rights and permissions
About this article
Cite this article
Tschaharganeh, D., Ehemann, V., Nussbaum, T. et al. Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference. Pathol. Oncol. Res. 13, 84–90 (2007). https://doi.org/10.1007/BF02893482
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02893482